Cargando…

CSF Potential Biomarkers Aβ42 and Tau: associations of Apo E Genotype

Detalles Bibliográficos
Autores principales:	Kandimalla, Ramesh, Gill, KD, Prabhakar, SK
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991786/ http://dx.doi.org/10.1186/1744-859X-9-S1-S104

Ejemplares similares

Tau in serum and CSF during cerebral injury
por: Van Droogenbroeck, P, et al.
Publicado: (1997)

CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
por: Henjum, Kristi, et al.
Publicado: (2018)

CSF p-Tau levels in the prediction of Alzheimer's disease
por: Kandimalla, Ramesh J. L., et al.
Publicado: (2013)

Phylloides tumours: review of 42 cases
por: Chandrasekharan, S, et al.
Publicado: (2002)

ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice
por: Liraz, Ori, et al.
Publicado: (2013)

P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status
por: Campbell, Michelle R., et al.
Publicado: (2021)

Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β ((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop
por: Teunissen, Charlotte E., et al.
Publicado: (2010)

Diagnostic Utility of CSF Tau and Aβ (42) in Dementia: A Meta-Analysis
por: Agarwal, Rachna, et al.
Publicado: (2011)

Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population
por: Monge-Argilés, J. A., et al.
Publicado: (2016)

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4
por: Andreasson, U, et al.
Publicado: (2014)

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia
por: Oh, Esther S., et al.
Publicado: (2018)

An association of CSF apolipoprotein E glycosylation and amyloid-beta 42 in individuals who carry the APOE4 allele
por: Meuret, Cristiana J., et al.
Publicado: (2023)

CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders
por: Mattsson, N, et al.
Publicado: (2013)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

Correction: Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia
Publicado: (2018)

Plasma p‐tau181/Aβ(1‐42) ratio predicts Aβ‐PET status and correlates with CSF‐p‐tau181/Aβ(1‐42) and future cognitive decline
por: Fowler, Christopher J., et al.
Publicado: (2022)

APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals – a cross-sectional observational study
por: Cysique, Lucette A, et al.
Publicado: (2015)

siRNA against presenilin 1 (PS1) down regulates amyloid β42 production in IMR-32 cells
por: Kandimalla, Ramesh JL, et al.
Publicado: (2012)

CSF T-Tau/Aβ(42) Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer’s Disease
por: Bendlin, Barbara B., et al.
Publicado: (2012)

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
por: Baek, Min Seok, et al.
Publicado: (2020)

Circulating soluble apo 2L, soluble OX-2: a possible screening biomarker for stage-4 ovarian, endometrial CA
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

Ventricular volume in relation to lumbar CSF levels of amyloid-β 1–42, tau and phosphorylated tau in iNPH, is there a dilution effect?
por: Lidén, Simon, et al.
Publicado: (2022)

The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone
por: Delaby, Constance, et al.
Publicado: (2022)

Ratio of Aβ42/P-tau(181p) in CSF is associated with aberrant default mode network in AD
por: Li, Xiaozhen, et al.
Publicado: (2013)

Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort
por: Cong, Wang, et al.
Publicado: (2017)

Early Differences in Cognition Associated With Familial Longevity and ApoE Genotype Using Digital Technology
por: Andersen, Stacy, et al.
Publicado: (2020)

PW02-033 - Cytokine profile in CSF in CAPS patients
por: Schuh, E, et al.
Publicado: (2013)

Cell-free Fc-γ receptors IIIb, autoantibodies and related immune complexes trigger the production of G-CSF and GM-CSF in nonorgan-specific autoimmune diseases
por: Durand, V, et al.
Publicado: (2002)

Combined Analysis of CSF Tau, Aβ42, Aβ1–42% and Aβ1–40(ox)% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia
por: Bibl, Mirko, et al.
Publicado: (2010)

42nd International Symposium on Intensive Care & Emergency Medicine
Publicado: (2023)

Anti-Fcgamma receptor (FcgammaR) autoantibodies (Ab) delay apoptosis of polymorphonuclear cells (PMN) in systemic autoimmune diseases by inducing the production of G-CSF and GM-CSF
por: Durand, V, et al.
Publicado: (2001)

Blood–Brain Barrier Dysfunction and Aβ42/40 Ratio Dose-Dependent Modulation with the ApoE Genotype within the ATN Framework
por: Toniolo, Sofia, et al.
Publicado: (2023)

Aβ1-42 and Tau as Potential Biomarkers for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis
por: Lanznaster, Débora, et al.
Publicado: (2020)

PICALM rs3851179 Variants Modulate Left Postcentral Cortex Thickness, CSF Amyloid β42, and Phosphorylated Tau in the Elderly
por: Wu, Zhiwei, et al.
Publicado: (2022)

Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays
por: Blennow, Kaj, et al.
Publicado: (2019)

CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer’s Disease and Frontotemporal Dementias
por: Constantinides, Vasilios C., et al.
Publicado: (2023)

Delayed paraplegia after thoracoabdominal aortic aneurysm repair announced by changes in CSF
por: Imberti, R, et al.
Publicado: (2003)

EHMTI-0149. Low CSF hypocretin-1 levels are associated with cluster headache
por: Barloese, M, et al.
Publicado: (2014)

EHMTI-0150. A controlled study of sleep in cluster headache patients.apo04
por: Barloese, M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9p7u75ds7l6s058acmemhf6jnp